
World number one tennis player Jannik Sinner has been handed a three-month suspension following a doping controversy that has sent shockwaves through the tennis community. The ban, effective from February 9 to May 4, 2025, means Sinner will miss several key tournaments, including the Monte Carlo Masters and Madrid Open.
The issue stems from two positive tests for clostebol, an anabolic steroid, in March 2024. Sinner attributed the presence of the substance to accidental contamination during a massage by his physiotherapist, Giacomo Naldi, who had used a spray containing clostebol to treat a personal injury. An independent tribunal accepted this explanation, determining there was no fault or negligence on Sinner’s part.
However, the World Anti-Doping Agency (WADA) appealed this decision, seeking a suspension of one to two years. After further proceedings, Sinner agreed to a three-month ban, allowing him to return just ahead of the French Open, which begins on May 25, 2025.
The tennis world has reacted with surprise and debate over the leniency of the sanction. Some players and fans question the fairness of the decision, given the strict nature of anti-doping regulations. Notably, Australian player Nick Kyrgios expressed dissatisfaction, highlighting perceived inconsistencies in doping sanctions within the sport.
As Sinner serves his suspension, the tennis community remains divided over the implications of this case for the sport’s integrity and the consistency of its doping policies.